Table 2.
A survey of existing microfluidic exosome separation methods
| Type | Methods | Throughput | Recovery rate of exosomes | Purity of recovered exosomes | Biological samples used in the study | Reference |
|---|---|---|---|---|---|---|
| Label-free (size-based) | Nano-DLD | 0.012 μL /h | N/A | N/A | Human urine | 48 |
| Acoustics | 240 μL/h | 82% | 98.4% | Whole blood, cell culture medium | 47 | |
| Pinched-flow fractionation | 1200 μL/h | N/A | N/A | Cell culture medium | 45 | |
| AF4 | 267–1333 μL /h | N/A | N/A | Cell culture medium | 49 | |
| Nanowire trapping | 600 μL /h | 10% | N/A | Mixture of BSA, liposome and beads | 46 | |
| Viscoelastic | 200 μL/h | >80% | > 90% | Cell culture medium, pure serum | 31 | |
| ExoTIC | 5000 μL /h | >90% | N/A | Plasma, urine, lavage, cell culture medium | 24 | |
| Double filtration | 2400 μL/h | 92% | N/A | Cell culture medium, urine | 25 | |
| Exodisc-B/P | 180–900 μL/h | 76–88% | N/A | Whole blood, plasma, and cell culture medium | 26 | |
| FerroChip | 60–180 μL/h | 94.3% | 87.9% | Cell culture medium and serum | This work | |
| Label-based | iMER | 240 μL / h | 93% | N/A | Serum | 44 |
| CD63-modified herringbone groves | ∼ 800 μL / h | 42–94% | N/A | Serum and cell culture medium | 42 | |
| CD41-modified mica surface | 72 μL / h | N/A | N/A | Human plasma, | 41 | |
| ExoChip | 240 μL / h | N/A | N/A | Serum | 17 | |
| nPLEX | 500 μL / h | N/A | N/A | Ascites fluid | 43 | |
| Nano-IMEX | 3 μL / h | N/A | N/A | Diluted plasma | 19 |